Zenas BioPharma (ZBIO) Cash from Operations (2023 - 2026)
Zenas BioPharma (ZBIO) posted quarterly Cash from Operations of 75196000.0 for Q1 2026, down 102.95% year-over-year from 2546697436.93 in Q1 2025, and down 43.47% quarter-over-quarter from 52414000.0 in Q4 2025.
Zenas BioPharma (ZBIO) Cash from Operations (2023 - 2026) Analysis & Trends
Zenas BioPharma's Cash from Operations history runs 4 years deep, the most recent figure standing at 75196000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 102.95% year-over-year to 75196000.0; the TTM figure through Mar 2026 stood at 210478000.0 (down 52.94% YoY), while the FY2025 annual figure was 172333000.0, down 44.0% from the prior year.
- Cash from Operations for Q1 2026 stood at 75196000.0, down from 52414000.0 in the prior quarter.
- The five-year high for Cash from Operations was 15400000.0 in Q4 2023, with the low at 75196000.0 in Q1 2026.
- The 4-year median for Cash from Operations is 37802500.0 (2024), against an average of 38260300.0.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations slumped 150.35% in 2024, then sank 32.41% in 2025.
- Zenas BioPharma's Cash from Operations stood at 15400000.0 in 2023, then sank by 150.35% to 38554000.0 in 2024, then sank by 35.95% to 52414000.0 in 2025, then sank by 43.47% to 75196000.0 in 2026.
- Business Quant data shows ZBIO's Cash from Operations at 75196000.0 in Q1 2026, 52414000.0 in Q4 2025, and 41125000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Zenas BioPharma | 1.87 Bn | 748.44 Mn | - | -57.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -57.24 Mn |
| Jun 30, 2026 | -57.24 Mn |
| Mar 31, 2026 | -75.20 Mn |
| Mar 31, 2026 | -75.20 Mn |
| Dec 31, 2025 | -52.41 Mn |
| Dec 31, 2025 | -52.41 Mn |
| Sep 30, 2025 | -41.13 Mn |
| Sep 30, 2025 | -41.13 Mn |
| Jun 30, 2025 | -41.74 Mn |
| Jun 30, 2025 | -41.74 Mn |
| Mar 31, 2025 | -37.05 Mn |
| Mar 31, 2025 | -37.05 Mn |
| Dec 31, 2024 | -38.55 Mn |
| Dec 31, 2024 | -38.55 Mn |
| Sep 30, 2024 | -31.06 Mn |
| Sep 30, 2024 | -31.06 Mn |
| Jun 30, 2024 | -30.96 Mn |
| Jun 30, 2024 | -30.96 Mn |
| Mar 31, 2024 | -19.10 Mn |
| Mar 31, 2024 | -19.10 Mn |